Li-Yu Wang Selected Research

Kidney Transplantation

1/2017

Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Yu Wang Research Topics

Disease

22	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 05/2002
19	Infections 01/2021 - 01/2004
12	Neoplasms (Cancer) 03/2022 - 05/2002
12	Chronic Hepatitis B 01/2022 - 05/2008
12	Fibrosis (Cirrhosis) 01/2019 - 08/2007
9	Hepatitis B 10/2019 - 05/2007
7	Liver Diseases (Liver Disease) 08/2014 - 01/2007
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 05/2011
3	Liver Neoplasms (Liver Cancer) 01/2019 - 10/2004
3	Hepatitis C 08/2012 - 02/2005
2	Body Weight (Weight, Body) 07/2022 - 01/2009
2	Viral Pneumonia 06/2021 - 02/2021
2	Human Influenza (Influenza) 06/2021 - 02/2021
2	Atherosclerosis 01/2019 - 08/2009
2	Carotid Artery Diseases 01/2019 - 08/2009
2	Lung Neoplasms (Lung Cancer) 04/2018 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2017
2	Fatty Liver 08/2014 - 01/2009
2	Non-alcoholic Fatty Liver Disease 08/2009 - 01/2009
2	Insulin Resistance 08/2009 - 01/2009
2	Obesity 01/2009 - 07/2008
2	Viremia 01/2007 - 01/2007
1	Esophageal Squamous Cell Carcinoma 03/2022
1	Inflammation (Inflammations) 06/2021
1	Pneumonia (Pneumonitis) 06/2021
1	Virus Diseases (Viral Diseases) 06/2021
1	Weight Gain 06/2021
1	Overweight 11/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Hemorrhage 09/2017
1	Myocardial Infarction 09/2017
1	Stroke (Strokes) 09/2017
1	Atrial Fibrillation 09/2017
1	Thrombosis (Thrombus) 09/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	Disease Progression 01/2016
1	Overactive Urinary Bladder (Overactive Bladder) 08/2014

Drug/Important Bio-Agent (IBA)

21	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 05/2002
12	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2007
12	Hepatitis B e AntigensIBA 01/2019 - 07/2002
8	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2009
7	RNA (Ribonucleic Acid)IBA 01/2017 - 02/2005
5	Aflatoxin B1 (Aflatoxin B)IBA 01/2018 - 05/2007
4	Antiviral Agents (Antivirals)IBA 06/2021 - 05/2012
4	Surface Antigens (Surface Antigen)IBA 01/2019 - 05/2007
4	Biomarkers (Surrogate Marker)IBA 11/2018 - 04/2007
4	AflatoxinsIBA 03/2009 - 05/2007
3	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2017
2	Phospholipases (Phospholipase)IBA 06/2021 - 02/2021
2	AlbuminsIBA 01/2017 - 07/2007
2	ORALIT (ORS)IBA 01/2016 - 03/2009
2	HLA-DPB1 antigen (HLA DPB1)IBA 05/2015 - 10/2013
2	AntibodiesIBA 10/2014 - 07/2002
2	Transaminases (Aminotransferases)IBA 01/2014 - 08/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2013 - 02/2005
2	TrihalomethanesIBA 01/2010 - 10/2007
2	Drinking WaterIBA 01/2010 - 10/2007
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 07/2007 - 05/2002
1	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2022
1	Caspase 9IBA 03/2022
1	rutecarpineIBA 03/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2022
1	Caspase 3 (Caspase-3)IBA 03/2022
1	daidzeinIBA 06/2021
1	arctiinIBA 06/2021
1	liquiritinIBA 06/2021
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 06/2021
1	HLA-DPA1 antigen (HLA DPA1)IBA 10/2019
1	LipidsIBA 01/2019
1	SugarsIBA 01/2019
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2019
1	low density lipoprotein inhibitorIBA 11/2018
1	TeaIBA 11/2018
1	oxidized low density lipoproteinIBA 11/2018
1	LeptinIBA 11/2018
1	LDL CholesterolIBA 11/2018
1	linderalactoneIBA 04/2018
1	Nucleoside-Diphosphate KinaseIBA 04/2018
1	Matrix Metalloproteinases (MMPs)IBA 04/2018
1	CateninsIBA 04/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 09/2017
1	AnticoagulantsIBA 09/2017
1	CarbonIBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	QuercetinIBA 01/2016

Therapy/Procedure

2	Therapeutics 07/2017 - 07/2014
2	Renal Dialysis (Hemodialysis) 01/2007 - 01/2007
2	Peritoneal Dialysis 01/2007 - 01/2007
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2007 - 01/2007
1	Oral Administration 06/2021
1	Meditation 01/2018
1	Stents 09/2017
1	Percutaneous Coronary Intervention 09/2017
1	Operative Surgical Procedures 01/2017
1	Kidney Transplantation 01/2017
1	Operative Time 01/2017